Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study.
Tanaka Y, Harigai M, Takeuchi T, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Kanazawa M, Oba T, Yoshinari T, Baker D; GO-FORTH Study Group. Tanaka Y, et al. Among authors: yamanaka h. Ann Rheum Dis. 2012 Jun;71(6):817-24. doi: 10.1136/ard.2011.200317. Epub 2011 Nov 25. Ann Rheum Dis. 2012. PMID: 22121129 Free PMC article. Clinical Trial.
MHC2TA is associated with rheumatoid arthritis in Japanese patients.
Iikuni N, Ikari K, Momohara S, Tomatsu T, Hara M, Yamanaka H, Okamoto H, Kamatani N. Iikuni N, et al. Among authors: yamanaka h. Ann Rheum Dis. 2007 Feb;66(2):274-5. doi: 10.1136/ard.2006.063347. Epub 2006 Nov 7. Ann Rheum Dis. 2007. PMID: 17090564 Free PMC article. No abstract available.
Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA).
Yamanaka H, Inoue E, Tanaka E, Nakajima A, Taniguchi A, Terai C, Hara M, Tomatsu T, Kamatani N. Yamanaka H, et al. Mod Rheumatol. 2007;17(2):98-105. doi: 10.1007/s10165-006-0546-7. Epub 2007 Apr 20. Mod Rheumatol. 2007. PMID: 17437163 Clinical Trial.
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2).
Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, Nawata M, Kameda H, Iwata S, Amano K, Yamanaka H. Tanaka Y, et al. Among authors: yamanaka h. Mod Rheumatol. 2008;18(2):146-52. doi: 10.1007/s10165-008-0026-3. Epub 2008 Feb 19. Mod Rheumatol. 2008. PMID: 18283523 Free PMC article.
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).
Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Takeuchi T, et al. Among authors: yamanaka h. Mod Rheumatol. 2008;18(5):447-54. doi: 10.1007/s10165-008-0077-5. Epub 2008 May 21. Mod Rheumatol. 2008. PMID: 18493716
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
Kobayashi S, Ikari K, Kaneko H, Kochi Y, Yamamoto K, Shimane K, Nakamura Y, Toyama Y, Mochizuki T, Tsukahara S, Kawaguchi Y, Terai C, Hara M, Tomatsu T, Yamanaka H, Horiuchi T, Tao K, Yasutomo K, Hamada D, Yasui N, Inoue H, Itakura M, Okamoto H, Kamatani N, Momohara S. Kobayashi S, et al. Among authors: yamanaka h. Arthritis Rheum. 2008 Jul;58(7):1940-6. doi: 10.1002/art.23494. Arthritis Rheum. 2008. PMID: 18576330 Free article.
Postmarketing surveillance of the safety and effectiveness of etanercept in Japan.
Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Freundlich B, Suzukawa M. Koike T, et al. Among authors: yamanaka h. J Rheumatol. 2009 May;36(5):898-906. doi: 10.3899/jrheum.080791. Epub 2009 Mar 30. J Rheumatol. 2009. PMID: 19332630 Free article.
1,888 results